Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Description

This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.

Conditions

Alzheimer's Disease, Mild Cognitive Impairment

Talk to us

Study Overview

On this page

Study Details

Study overview

This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.

A Randomized, Blinded, Controlled Trial of Music Therapy Singing Interventions for Patients With MCI and AD

Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Condition
Alzheimer's Disease
Intervention / Treatment

-

Contacts and Locations

New York

Louis Armstrong Center for Music and Medicine, Mount Sinai Beth Israel, New York, New York, United States, 10003

New York

Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, United States, 10029

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of Alzheimer's disease or mild cognitive impairment
  • * Must have study partner
  • * English speaking
  • * No verbal impairment
  • * Community-dwelling
  • * Must have webcam or smart phone
  • * A diagnosis of dementia other than probable or possible AD
  • * Probable AD with Down syndrome
  • * History of a clinically significant stroke with residual deficit
  • * Current evidence or history in past two years of epilepsy, focal brain lesion, head injury
  • * Current diagnosis for major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse.
  • * Participation in another interventional study
  • * Comorbidity causing disability interfering with intervention such as pain or discomfort or life expectancy less than 1 year

Ages Eligible for Study

55 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Icahn School of Medicine at Mount Sinai,

Mary Sano, PhD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Joanne Loewy, DA, LCAT, MT-BC, PRINCIPAL_INVESTIGATOR, Mount Sinai Beth Israel

Study Record Dates

2025-07